type 2 diabetes
The miR-34a/NAMPT axis presents a potential target for treating obesity- and aging-related diseases involving SIRT1 dysfunction like steatosis and type 2 diabetes.
The miR-34a/NAMPT axis presents a potential target for treating obesity- and aging-related diseases involving <span class="gene" id="23834033-13-110-115">SIRT1</span> dysfunction like steatosis and <span class="disease" id="23834033-13-147-162">type 2 diabetes</span>.